The week in review

Potential buyers circle Infinity Group, an herbalist sentenced and a new anaphylaxis product were among the topics that had our readers talking this week Sigma Healthcare, and private equity firm, Genesis Capital, are believed to be frontrunners to acquire the Infinity group, following Wesfarmers Health’s decision to appoint receivers late last year.   While a spokesperson for Sigma declined to comment on speculation, the company, which